top of page
pile-of-document-ring-binders-2023-11-27-04-50-24-utc.JPG

REPORTS

old-handwriting-with-metallic-chains-2023-11-27-05-04-17-utc.jpg

In 2016, the Centers for Disease Control and Prevention issued guidelines regarding the use of opioid analgesics for the treatment of chronic pain.

 

Our report, Violation of A Nation, explores the work that led to the issuance of these guidelines.  We reveal the regulations and policies enabling clinical trials to take place without participant knowledge or consent. 

​

Lauren Deluca and Shasta Rayne Harner, conducted 9 Congressional and Senatorial meetings in April 2019, presenting our findings within Violation of a Nation.  As a result, we successfully obtained the FDA Safety Announcement against the practice of forced and/or abrupt discontinuation of opioid medication.

Violation of A Nation Rebranded September 2024.png
A Crisis Exploited Rebranded September 2024.png

This investigative research report explores the relationships between Physicians for Responsible Opioid Prescribing, Pacira Pharmaceuticals, American Chronic Pain Association, BioDelivery Sciences International, Indivior, Steve Rummler HOPE Foundation, FedUp! Rally, FedUp!
Coalition, Shatterproof and US Pain Foundation as well as their Board of Directors.  We present the activities of these organizations and other federal agencies in the creation of the nation's opioid-sparing policies and overarching strategic plans. We explore subjects, such as, the 2016 CDC's Opioid Prescribing Guidelines, the National Pain Strategy, Inter-Agency Pain Research Coordinating Committee and Federal Pain Research Strategy.

This report offers our unique analysis and recommendations regarding the use of public-private partnerships.  

 

An integral part of creating successful public-private partnerships is ensuring proper systems are in place to address issues related to bias, conflicts of interest, and other acts of corruption, including, but not limited to: scientific fraud, anti-trust violations and/or data and financial market abuses.

Ethical Guidance in Public-Private Partnerships Rebranded September 2024.png
Untitled-2.png

In 2016, the Centers for Disease Control & Prevention published national guidelines on the prescription of opioid-based medications for the treatment of pain and illness.  These guidelines recommended maximum daily values and other restrictions on the prescribing of opioid analgesics to treat pain.

​

Citizens Interest provides an in-depth analysis the guideline update which uncovered serious conflicts of interest, author bias, and a lack of evidence to support the recommendations being made by the guideline itself.  Throughout the revised guidelines, the author's repeatedly cite a lack of evidence or research and then proceed to advise these same modalities to be labeled "evidence-based best-practices" despite a total lack of supporting evidence. 

​

The guidelines are used to direct patient care to engage in treatment modalities that possess little to no evidence of efficacy.  Citizens Interest's research reveals this was done in an effort to align patient care with research goals outlined in HHS Pain Management Task Force Report and the HEALTHY PEOPLE Campaign.

bottom of page